Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Consun Pharmaceutical Group Limited

Market Cap 10.04B 1.48B 1.29B 1.19B 1.11B 2.08B 142B 2.12B 14.14B 5.47B 68.39B 5.56B 5.44B 238B P/E Ratio 2026 *
8.14x
P/E Ratio 2027 * 7.39x
Enterprise Value 10.04B 1.48B 1.29B 1.19B 1.11B 2.08B 142B 2.12B 14.14B 5.47B 68.39B 5.56B 5.44B 238B EV / Sales 2026 *
2.59x
EV / Sales 2027 * 2.31x
Free-Float
53.9%
Yield 2026 *
6.19%
Yield 2027 * 6.82%
1 day-0.68%
1 week-1.34%
Current month-1.34%
1 month-8.70%
3 months-22.22%
6 months-8.12%
Current year-10.37%
1 week 1.45
Extreme 1.45
1.53
1 month 1.45
Extreme 1.45
1.7
Current year 1.45
Extreme 1.45
2.18
1 year 1.04
Extreme 1.04
2.18
3 years 0.07
Extreme 0.071
2.18
5 years 0.07
Extreme 0.071
2.18
10 years 0.07
Extreme 0.071
2.18
Manager TitleAgeSince
Chief Executive Officer 54 17/01/2024
Director of Finance/CFO 46 24/02/2025
Corporate Secretary 58 -
Director TitleAgeSince
Director/Board Member 86 24/12/2012
Director/Board Member 67 02/12/2013
Director/Board Member 43 24/02/2025
Change 5-day change 1-year change 3-year change Capi.($)
-0.68%-1.34% - - 1.49B
+0.44%+0.32%+6.24%+82.35% 44.99B
-0.44%-7.89%+40.02%+89.26% 33.69B
+0.69%+2.72%+12.64%+117.80% 11.6B
+0.46%+0.59%-8.44%+42.72% 11.68B
+1.27%+0.39%+36.17%+125.55% 8.94B
-1.44%-1.94%+15.12%+39.86% 7.01B
+0.00%-1.36%+32.74%+237.16% 6.35B
+0.61%+3.68%+45.01%-16.20% 6.51B
-0.45%-3.68%-38.58%-6.82% 5.15B
Average +0.09%-0.93%+15.66%+79.07% 15.1B
Weighted average by Cap. +0.17%-1.81%+17.72%+83.47%

Financials

2026 *2027 *
Net sales 3.88B 573M 497M 458M 429M 802M 54.86B 819M 5.47B 2.12B 26.45B 2.15B 2.1B 91.95B 4.35B 642M 557M 514M 481M 899M 61.48B 918M 6.13B 2.37B 29.64B 2.41B 2.36B 103B
Net income 1.24B 182M 158M 146M 137M 255M 17.46B 261M 1.74B 674M 8.42B 685M 670M 29.27B 1.36B 201M 174M 161M 151M 282M 19.25B 287M 1.92B 743M 9.28B 755M 739M 32.27B
Net Debt - -
Logo Consun Pharmaceutical Group Limited
Consun Pharmaceutical Group Ltd is a company principally engaged in manufacturing and sales of pharmaceutical products. The Company operates its businesses through two segments. Consun Pharmaceutical segment is mainly engaged in manufacturing and sells of modern Chinese medicines and medical contrast medium. Yulin Pharmaceutical segment is mainly involved in manufacturing and sells of traditional Chinese medicines. The Company's products include kidney medicines, gynaecology and paediatrics medicines, contrast medium, orthopedics medicines, dermatologic medicines, hepatobiliary medicines and others. The Company mainly operates its businesses in the domestic market.
Employees
3,115
Date Price Change Volume
11/06/26 1.470 -0.68% 0
10/06/26 1.480 +0.68% 0
09/06/26 1.470 -3.92% 0
08/06/26 1.530 0.00% 0
05/06/26 1.530 +2.68% 0
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
11.93CNY
Average target price
20.51CNY
Spread / Average Target
+71.94%

Annual profits - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!